Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.57
-
NAV
₹15.95
-
Fund Started
16 Jan 2024
-
Fund Size
₹664.02 Cr
-
Exit Load
-
-
1 Year
14.48%
-
3 Year
-
-
5 Year
-
-
Equity
99.10%
-
Cash
-7.04%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.56% |
JB Chemicals & Pharmaceuticals Ltd. | 6.80% |
Apollo Hospitals Enterprise Ltd. | 4.83% |
Laurus Labs Ltd. | 4.43% |
Fortis Healthcare Ltd. | 3.92% |
Krishna Institute of Medical Sciences Ltd | 3.44% |
Divi's Laboratories Ltd. | 3.29% |
Sai Life Sciences Ltd. | 3.17% |
Max Healthcare Institute Ltd. | 2.83% |
Aurobindo Pharma Ltd. | 2.62% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
-
Launch Date
16 Jan 2024
-
